InsidersTradesSigma
Track the 九芝堂 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 九芝堂 has published 7 public disclosures. Market capitalisation: €7.6bn. The latest transaction was reported on 27 October 2022 (Sale). Among the most active insiders: 李振国. All data is accessible without an account.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€112m
7 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,415 of 29,062 companies
60.3
score / 100
Value48
Quality72
FCF yld5.1%
Earn yld2.9%
EV/EBITDA17.8x
ROE8.1%
Gross mgn60%
Net mgn10.0%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 October 2022
Declarations7 total
670,600 sharesA股XSHESZSE:173000005992096740
7 of 7 declarations
About 九芝堂
九芝堂 is a company in the health and pharmaceutical sector, known for its traditional Chinese products. It is listed on the XSHE market.